SCHEMBL6631313

SCHEMBL6631313

COC(=O)CN1CCc2sccc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.49
ABCB11 O95342 3/20 0.46
ALDH1A1 P00352 3/20 0.46
ADRA2A P08913 2/20 0.46
CYP2B6 P20813 2/20 0.46
DRD1 P21728 2/20 0.46
OPRM1 P35372 2/20 0.46
OPRK1 P41145 2/20 0.46
HTR2B P41595 2/20 0.46
KCNH2 Q12809 2/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
ADRB3 P13945 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6369881 0.82 ALDH1A1 (0.50) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
SCHEMBL5242060 0.81 ALDH1A1 (0.49) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
SCHEMBL28687701 0.80 CYP2C19 (0.55) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
Water SCHEMBL11003040 0.80 ALDH1A1 (0.47) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
SCHEMBL5862011 0.78 KMT2A (0.61) ALDH1A1MAPK1KDM4ETSHRPRMT5
SCHEMBL8801055 0.77 CYP2C19 (0.47) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
Hydrochloric Acid SCHEMBL6635562 0.76 MAPK1 (0.57) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
SCHEMBL8802005 0.76 ALDH1A1 (0.53) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
Hydrochloric Acid SCHEMBL6659698 0.76 NPSR1 (0.45) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6
Hydrochloric Acid SCHEMBL6659697 0.76 CYP2C19 (0.48) CYP2C19ABCB11ALDH1A1ADRA2ACYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656381-B1 CRYSTALLISATION OF SOLID FORMS OF CLOPIDOGREL ADDITION SALTS KRKA TORVARNA ZDRAVIL D D NOVO MESTO (SI) 2011-03-09 EP disclosed
CN-100522970-C Stereoselective method for the production of clopidogrel RATIOPHARM GMBH (DE) 2009-08-05 CN disclosed
CN-1318428-C Thiophenopyridine substituted acetyl hyarazine derivative TIANJIN MEDICINE INST (CN) 2007-05-30 CN disclosed
CN-1972950-A Stereoselective process for preparing clopidogrel RATIOPHARM GMBH (DE) 2007-05-30 CN disclosed
CN-1683373-A Thiophenopyridine substituted acetyl hyarazine derivative TIANJIN MEDICINE INST (CN) 2005-10-19 CN disclosed
EP-1438314-A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE ALPHA-PHENYL-APLPHA(6,7-DIHYDRO-4H-THIENO 3,2-C PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES Merck Generics (UK) Limited (GB) 2004-07-21 EP disclosed
WO-2003035652-A9 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES MERCK GENERICS UK LTD (GB) 2004-04-08 WO disclosed
WO-2003035652-A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES MERCK GENERICS [UK] LIMITED (GB) 2003-05-01 WO disclosed